According to Ravi Nathani, an independent technical analyst, the Nifty Pharma index is quoting close to its ley support at 18,325; hence one may consider a buy on dip strategy here.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
